Go to JCI Insight
Jci spelled out white on transparent.20160208
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Cellular senescence in human disease (Apr 2018)
    • Fibrosis (Jan 2018)
    • Glia and Neurodegeneration (Sep 2017)
    • Transplantation (Jun 2017)
    • Nuclear Receptors (Apr 2017)
    • Metabolism and Inflammation (Jan 2017)
    • Hypoxia and Inflammation (Oct 2016)
    • View all review series...
  • Collections
    • Recently published
    • Commentaries
    • Concise Communication
    • Editorials
    • Opinion
    • Scientific Show Stoppers
    • Top read articles
    • In-Press Preview
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

Jci only white

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication

Review Series

NF-kappaB in defense and disease

Series edited by Albert S. Baldwin Jr.

NF-kappaB is a primary effector of human disease. The series highlights the evolutionary conservation of the NF-kappaB pathway and its regulation as well as the diverse functions the transcription factor has in human health and disease.

Articles in series

Toll-like receptor–mediated NF-κB activation: a phylogenetically conserved paradigm in innate immunity
Guolong Zhang, Sankar Ghosh
Guolong Zhang, Sankar Ghosh
Published January 1, 2001
Citation Information: J Clin Invest. 2001;107(1):13-19. https://doi.org/10.1172/JCI11837.
View: Text | PDF

Toll-like receptor–mediated NF-κB activation: a phylogenetically conserved paradigm in innate immunity

  • Text
  • PDF
Abstract

Authors

Guolong Zhang, Sankar Ghosh

×

Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
Yumi Yamamoto, Richard B. Gaynor
Yumi Yamamoto, Richard B. Gaynor
Published January 15, 2001
Citation Information: J Clin Invest. 2001;107(2):135-142. https://doi.org/10.1172/JCI11914.
View: Text | PDF

Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer

  • Text
  • PDF
Abstract

Authors

Yumi Yamamoto, Richard B. Gaynor

×

Hostile takeovers: viral appropriation of the NF-kB pathway
John Hiscott, … , Hakju Kwon, Pierre Génin
John Hiscott, … , Hakju Kwon, Pierre Génin
Published January 15, 2001
Citation Information: J Clin Invest. 2001;107(2):143-151. https://doi.org/10.1172/JCI11918.
View: Text | PDF

Hostile takeovers: viral appropriation of the NF-kB pathway

  • Text
  • PDF
Abstract

Authors

John Hiscott, Hakju Kwon, Pierre Génin

×

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
Albert S. Baldwin
Albert S. Baldwin
Published February 1, 2001
Citation Information: J Clin Invest. 2001;107(3):241-246. https://doi.org/10.1172/JCI11991.
View: Text | PDF

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB

  • Text
  • PDF
Abstract

Authors

Albert S. Baldwin

×

NF-κB in neuronal plasticity and neurodegenerative disorders
Mark P. Mattson, Simonetta Camandola
Mark P. Mattson, Simonetta Camandola
Published February 1, 2001
Citation Information: J Clin Invest. 2001;107(3):247-254. https://doi.org/10.1172/JCI11916.
View: Text | PDF

NF-κB in neuronal plasticity and neurodegenerative disorders

  • Text
  • PDF
Abstract

Authors

Mark P. Mattson, Simonetta Camandola

×

NF-κB: pivotal mediator or innocent bystander in atherogenesis?
Tucker Collins, Myron I. Cybulsky
Tucker Collins, Myron I. Cybulsky
Published February 1, 2001
Citation Information: J Clin Invest. 2001;107(3):255-264. https://doi.org/10.1172/JCI10373.
View: Text | PDF

NF-κB: pivotal mediator or innocent bystander in atherogenesis?

  • Text
  • PDF
Abstract

Authors

Tucker Collins, Myron I. Cybulsky

×

Series Introduction: The transcription factor NF-κB and human disease
Albert S. Baldwin Jr.
Albert S. Baldwin Jr.
Published January 1, 2001
Citation Information: J Clin Invest. 2001;107(1):3-6. https://doi.org/10.1172/JCI11891.
View: Text | PDF

Series Introduction: The transcription factor NF-κB and human disease

  • Text
  • PDF
Abstract

Authors

Albert S. Baldwin Jr.

×

NF-κB: a key role in inflammatory diseases
Paul P. Tak, Gary S. Firestein
Paul P. Tak, Gary S. Firestein
Published January 1, 2001
Citation Information: J Clin Invest. 2001;107(1):7-11. https://doi.org/10.1172/JCI11830.
View: Text | PDF

NF-κB: a key role in inflammatory diseases

  • Text
  • PDF
Abstract

Authors

Paul P. Tak, Gary S. Firestein

×

Advertisement
Follow JCI: Facebook logo white Twitter logo v2 Rss icon
Copyright © 2018 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts